These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7917508)

  • 21. The effect of activated charcoal on the absorption of fluoxetine, with special reference to delayed charcoal administration.
    Laine K; Kivistö KT; Pelttari S; Neuvonen PJ
    Pharmacol Toxicol; 1996 Nov; 79(5):270-3. PubMed ID: 8936562
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activated charcoal in theophylline intoxication.
    Brashear RE; Aronoff GR; Brier RA
    J Lab Clin Med; 1985 Sep; 106(3):242-5. PubMed ID: 4031629
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of chloroquine absorption by activated charcoal.
    Neuvonen PJ; Kivistö KT; Laine K; Pyykkö K
    Hum Exp Toxicol; 1992 Mar; 11(2):117-20. PubMed ID: 1349217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An evaluation of the effect of repeated doses of oral activated charcoal on salicylate elimination.
    Ho JL; Tierney MG; Dickinson GE
    J Clin Pharmacol; 1989 Apr; 29(4):366-9. PubMed ID: 2723125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activated charcoal alone and followed by whole-bowel irrigation in preventing the absorption of sustained-release drugs.
    Lapatto-Reiniluoto O; Kivistö KT; Neuvonen PJ
    Clin Pharmacol Ther; 2001 Sep; 70(3):255-60. PubMed ID: 11557913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the adsorption capacities of an activated-charcoal--yogurt mixture versus activated-charcoal--water slurry in vivo and in vitro.
    Hoegberg LC; Christophersen AB; Christensen HR; Angelo HR
    Clin Toxicol (Phila); 2005; 43(4):269-75. PubMed ID: 16035203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute dapsone intoxication: clinical findings and effect of oral charcoal and haemodialysis on dapsone elimination.
    Neuvonen PJ; Elonen E; Haapanen EJ
    Acta Med Scand; 1983; 214(3):215-20. PubMed ID: 6660028
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of charcoal-drug ratio on antidotal efficacy of oral activated charcoal in man.
    Olkkola KT
    Br J Clin Pharmacol; 1985 Jun; 19(6):767-73. PubMed ID: 4027120
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple-dose activated charcoal compared to urinary alkalinization for the enhancement of phenobarbital elimination.
    Frenia ML; Schauben JL; Wears RL; Karlix JL; Tucker CA; Kunisaki TA
    J Toxicol Clin Toxicol; 1996; 34(2):169-75. PubMed ID: 8618250
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factors influencing the clinical efficacy of activated charcoal.
    Watson WA
    Drug Intell Clin Pharm; 1987 Feb; 21(2):160-6. PubMed ID: 3549212
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection and determination of free and plasma protein-bound astemizole by thin-layer chromatography: a useful technique for bioavailability studies.
    Mangalan S; Patel RB; Gandhi TP; Chakravarthy BK
    J Chromatogr; 1991 Jul; 567(2):498-503. PubMed ID: 1939483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of phenobarbitone poisoning with repeated oral administration of activated charcoal.
    Boldy DA; Vale JA; Prescott LF
    Q J Med; 1986 Nov; 61(235):997-1002. PubMed ID: 3659250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of phenobarbital overdose with activated charcoal.
    Goldberg MJ; Berlinger WG
    JAMA; 1982 May; 247(17):2400-1. PubMed ID: 7069899
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Seromucosal transport of intravenously administered carbamazepine is not enhanced by oral doses of activated charcoal in rats.
    Eyer F; Jung N; Neuberger H; Witte A; Poethko T; Henke J; Zilker T
    Basic Clin Pharmacol Toxicol; 2008 Mar; 102(3):337-46. PubMed ID: 18248517
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of activated charcoal on the bioavailability of piroxicam in man.
    Laufen H; Leitold M
    Int J Clin Pharmacol Ther Toxicol; 1986 Jan; 24(1):48-52. PubMed ID: 3957490
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of activated charcoal on absorption of nortriptyline.
    Crome P; Dawling S; Braithwaite RA; Masters J; Walkey R
    Lancet; 1977 Dec; 2(8050):1203-5. PubMed ID: 73903
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute valproic acid overdose: enhance elimination with multiple-doses activated charcoal.
    Vannaprasaht S; Tiamkao S; Sirivongs D; Piyavhatkul N
    J Med Assoc Thai; 2009 Aug; 92(8):1113-5. PubMed ID: 19694338
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gastrointestinal dialysis of disopyramide in healthy subjects.
    Arimori K; Kawano H; Nakano M
    Int J Clin Pharmacol Ther Toxicol; 1989 Jun; 27(6):280-4. PubMed ID: 2737797
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of ipecac and activated charcoal/cathartic. Prevention of salicylate absorption in a simulated overdose.
    Curtis RA; Barone J; Giacona N
    Arch Intern Med; 1984 Jan; 144(1):48-52. PubMed ID: 6140906
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral activated charcoal and dapsone elimination.
    Neuvonen PJ; Elonen E; Mattila MJ
    Clin Pharmacol Ther; 1980 Jun; 27(6):823-7. PubMed ID: 7379451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.